Among those, as previously mentioned, the increased expression of ptpn6 in KIRC and TGCT is significantly correlated with poor prognosis and high immune infiltration, reflecting the potential associations of ptpn6 promoter methylation, gene expression, and its role in cancer prognosis and immune infiltration. This evidence concerns the gene PTPN6 and cancer.